Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Actuate Therapeutics Inc.
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
University of Nebraska
Takeda
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
UNC Lineberger Comprehensive Cancer Center
Centre Hospitalier Universitaire de Besancon
University Health Network, Toronto
AstraZeneca
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
Hadassah Medical Organization
University of Colorado, Denver
A2 Biotherapeutics Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
University of California, San Francisco
A2 Biotherapeutics Inc.
Genentech, Inc.
Institut Bergonié
Tampere University Hospital
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Columbia University
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
Pfizer
University Health Network, Toronto
Universidade Federal de Pernambuco
Taproot Health
Astellas Pharma Inc
Astellas Pharma Inc
Dana-Farber Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Sydney
Second Affiliated Hospital of Guangzhou Medical University
Cedars-Sinai Medical Center
Sanguine Biosciences